The long-awaited Gene Technology Bill has stalled because New Zealand First won’t support it as it stands. The sticking point ...
Bio-Gene Technology Ltd. ( ($AU:BGT) ) has shared an announcement. Bio-Gene Technology Limited reported significant progress in Q1 FY26, including ...
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
New research posits that a genetic incompatibility between female offspring of humans and Neanderthals and their children ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...
AI is set to shake up the investment management industry, but Gene Munster says the right mix of these soft skills could help ...
Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...
Pharmaceutical Technology on MSN
Eli Lilly buys Adverum in eye disease gene therapy punt
Eli Lilly has agreed to acquire eye disease specialist Adverum Biotechnologies, bucking a recent trend of big pharma ...
We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.
Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...
Samsung Group said Thursday it will invest in Arbor Biotechnologies, a US-based gene editing company, through its Life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results